Dimerix Limited (ASX: DXB, "Dimerix") a clinical-stage biopharmaceutical company developing kidney disease treatments, is pleased to announce that it has acquired DMX-652 for all indications from ...

Highlights Dimerix acquires Phase 2-ready asset, DMX-652 - with potential for rapid advancement into a Phase 2 clinical study under an open US Investigational New ...

It's been a journey for Arieauna Johnson as her mother, Melissa, battles kidney failure. "It’s been difficult. That’s why ...

From organizing the local bingo in Richer to supporting rural food banks and helping students pursue their ...

A review suggests that although obesity medications, such as GLP-1 drugs, can result in substantial weight loss, many obesity ...

Longevity medicine relies on advanced biomarker analysis to support preventive healthcare and more personalized patient ...

Learn more about whether ACADIA Pharmaceuticals Inc. or CareDx, Inc. is a better investment based on AAII's A+ Investor ...

Discover the 12 everyday mistakes causing energy loss after 50 and what actually helps. The post 12 Everyday Habits That Are ...

Detailed price information for Vor Biopharma Inc (VOR-Q) from The Globe and Mail including charting and trades.

Dimerix expands kidney pipeline with DMX-652 acquisition; Phase 2-ready AKI therapy targets US$3.5b market, upfront US$5m ...

Find the best dog food with advice from veterinarians. These picks meet AAFCO standards and WSAVA nutrition guidelines for every life stage.

(Nasdaq: GILD) today announced that the European Commission (EC) has granted marketing authorization for Trodelvy ® (sacituzumab govitecan-hziy) as monotherapy for the treatment of adult patients with ...